Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Natali, A.
Oxford, J. S.
and
Schild, G. C.
1981.
Frequency of naturally occurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody.
Journal of Hygiene,
Vol. 87,
Issue. 2,
p.
185.
Burrows, R.
and
Denyer, M.
1982.
Antigenic properties of some equine influenza viruses.
Archives of Virology,
Vol. 73,
Issue. 1,
p.
15.
Oxford, J. S.
Yetts, R.
and
Schild, G. C.
1982.
Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis.
Journal of Hygiene,
Vol. 88,
Issue. 2,
p.
325.
Drescher, H. J.
1983.
Teil I: Referate.
p.
113.
Mumford, Jennifer
Wood, J. M.
Scott, A. M.
Folkers, C.
and
Schild, G. C.
1983.
Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
Journal of Hygiene,
Vol. 90,
Issue. 3,
p.
385.
Mancini, G.
Donatelli, I.
Arangio Ruiz, G.
and
Rozera, C.
1984.
Detection of antibodies to strain-specific and cross-reactive antigenic determinants on the haemagglutinin of influenza viruses A/Texas/1/77 and A/Bangkok/1/79 in human sera.
Archives of Virology,
Vol. 79,
Issue. 1-2,
p.
117.
Natali, Anita
Panizzi, P. F.
Chezzi, C.
and
Oxford, J. S.
1984.
Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selectedin vitro.
Journal of Hygiene,
Vol. 92,
Issue. 2,
p.
243.
1985.
Conquest of Viral Diseases - A Topical Review of Drugs and Vaccines.
Vol. 1,
Issue. ,
p.
31.
Pyhälä, R.
Kleemola, M.
and
Visakorpi, R.
1985.
The HI test modified by ether treatment in the sero-epidemiological surveillance of influenza B.
Journal of Hygiene,
Vol. 94,
Issue. 3,
p.
341.
Ada, G. L.
and
Jones, P. D.
1986.
Current Topics in Microbiology and Immunology.
Vol. 128,
Issue. ,
p.
1.
Potter, C. W.
Jennings, R.
Ali, M. J.
Wood, J. M.
Dunleavy, U.
and
Tyrrell, D. A. J.
1987.
Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (Report to the Medical Research Council's Sub-Committee on Influenza Vaccines (CDVIP/IV)).
Epidemiology and Infection,
Vol. 99,
Issue. 2,
p.
501.
Natali, A.
and
Chezzi, C.
1991.
Use of monoclonal anti-haemagglutinin antibodies for the ?In vitro? selection of a sequential influenza virus antigenic variant.
European Journal of Epidemiology,
Vol. 7,
Issue. 4,
p.
384.
Kapaklis‐Deliyannis, Georgia P.
Drummer, Heidi E.
Brown, Lorena E.
Tannock, Gregory A.
and
Jackson, David C.
1993.
A study of the advantages and limitations of immunoblotting procedures for the detection of antibodies against influenza virus.
ELECTROPHORESIS,
Vol. 14,
Issue. 1,
p.
926.
Pyhälä, R.
Kumpulainen, V.
Alanko, S.
and
Forsten, T.
1994.
HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990–1992.
Vaccine,
Vol. 12,
Issue. 10,
p.
947.
Gelder, C M
Welsh, K I
Faith, A
Lamb, J R
and
Askonas, B A
1995.
Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection.
Journal of Virology,
Vol. 69,
Issue. 12,
p.
7497.
Brokstad, Karl Albert
Cox, Rebecca J.
Major, Diane
Wood, John M.
and
Haaheim, Lars R.
1995.
Cross-reaction but no avidity change of the serum antibody response after influenza vaccination.
Vaccine,
Vol. 13,
Issue. 16,
p.
1522.
Lambkin, R.
and
Dimmock, N.J.
1996.
Longitudinal study of an epitope-biased serum haemagglutination-inhibition antibody response in rabbits immunized with type A influenza virions.
Vaccine,
Vol. 14,
Issue. 3,
p.
212.
Jeon, Sung Ho
Ben-Yedidia, Tamar
and
Arnon, Ruth
2002.
Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus.
Vaccine,
Vol. 20,
Issue. 21-22,
p.
2772.
Hampson, Alan W.
2002.
Influenza.
Vol. 7,
Issue. ,
p.
49.
Smith, Dan J.
Bot, Simona
Dellamary, Luis
and
Bot, Adrian
2003.
Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus.
Vaccine,
Vol. 21,
Issue. 21-22,
p.
2805.